Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE4
160 participants
INTERVENTIONAL
2026-01-26
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pharmacokinetics of Intramuscular Adrenaline in Food--Allergic Teenagers
NCT03366298
Self-injection and Self-management
NCT02417493
What is the Allergy Follow-up for Children After Anaphylactic Reaction? AFCAR : Allergy Follow-up for Children After Anaphylactic Reaction
NCT03942692
Steroid Use in Pediatric Fluid and Vasoactive Infusion Dependent Shock - Pilot Study
NCT02044159
Epidemiology and Management of Pediatric Anaphylaxis and Allergy in the Pediatric Emergency Department of Montpellier
NCT05112367
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Antihistamines plus oral steroids
Participants receive oral antihistamines plus oral systemic corticosteroids for treatment of allergic reactions occurring during the oral food challenge. Intramuscular adrenaline may be administered as rescue medication if clinically indicated.
Antihistamines
Oral administration of antihistamines for treatment of allergic symptoms during the oral food challenge.
Systemic corticosteroids
Oral administration of systemic corticosteroids as adjunctive treatment of allergic reactions during the oral food challenge.
Adrenaline (rescue medication)
Intramuscular administration of adrenaline as rescue treatment for severe allergic reactions (anaphylaxis), administered as clinically indicated.
Antihistamines only (no steroids)
Participants receive oral antihistamines without systemic corticosteroids for treatment of allergic reactions occurring during the oral food challenge. Intramuscular adrenaline may be administered as rescue medication if clinically indicated.
Antihistamines
Oral administration of antihistamines for treatment of allergic symptoms during the oral food challenge.
Adrenaline (rescue medication)
Intramuscular administration of adrenaline as rescue treatment for severe allergic reactions (anaphylaxis), administered as clinically indicated.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Antihistamines
Oral administration of antihistamines for treatment of allergic symptoms during the oral food challenge.
Systemic corticosteroids
Oral administration of systemic corticosteroids as adjunctive treatment of allergic reactions during the oral food challenge.
Adrenaline (rescue medication)
Intramuscular administration of adrenaline as rescue treatment for severe allergic reactions (anaphylaxis), administered as clinically indicated.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Non-food allergies
* Age outside the specified range
* Contraindications for an oral food challenge or oral steroid use within one week before the challenge.
6 Months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Children's Hospital Basel
OTHER
Johannes Trueck
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Johannes Trueck
Head, Division of Allergy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Children's Hospital Basel
Basel, Basel, Switzerland
University Children's Hospital, Zürich
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HumRes67580
Identifier Type: REGISTRY
Identifier Source: secondary_id
SNCTP000006696
Identifier Type: REGISTRY
Identifier Source: secondary_id
BASEC-2025-00320
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.